Investigation Into the Equine Metabolism of Phosphodiesterase‐4 Inhibitor Roflumilast for Potential Doping Control
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3822 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Moses Philip und 7 weiteren Autor:innen. Beteiligte Einrichtung: Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, UAE. Hauptthemen laut MEDLINE: Phosphodiesterase 4 Inhibitors, Aminopyridines, Benzamides, Doping in Sports. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
The phosphodiesterase 4 (PDE4) inhibitors constitute a relatively modern class of medications that are known for inducing bronchodilation and exhibiting anti‐inflammatory properties within the body. Due to these properties, there is concern regarding their potential misuse as performance‐enhancing substances in competitive sports. This study delves into the metabolic conversion of roflumilast in thoroughbred horses following oral administration and in vitro experimentation using equine liver microsomes and Cunninghamella elegans . High‐performance liquid chromatography coupled with a Q Exactive Orbitrap mass spectrometer (HPLC‐HRMS) was employed for analysis. The investigation identified 10 metabolites of roflumilast, including six phase I and four phase II metabolites from in vivo studies, and 11 metabolites from in vitro studies, consisting of eight phase I and three phase II metabolites. The identified biotransformation products encompassed processes such as hydroxylation, chlorine substitution, methylation, N ‐oxide formation, and even the dissociation of methylenecyclopropane and difluoromethane. Furthermore, the study identified three glucuronic acid and one sulfonic acid conjugated phase II metabolites of the investigated drug candidate. The aforementioned findings contribute to the detection and comprehension of the unauthorized utilization of roflumilast in equestrian sports.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Equine Forensic Unit, Central Veterinary Research Laboratory, Dubai, UAE.
- Department of Bacteriology, Diagnostic Section, Central Veterinary Research Laboratory, Dubai, UAE.
ORCID-Profile: Abdul Khader Karakka Kal, Michael Benedict Subhahar, Tajudheen K Karatt
Zitieren
APA
Philip, M., Karakka Kal, A. K., Subhahar, M. B., Karatt, T. K., Graiban, F. M., Ajeebsanu, M. M., Joseph, M., & Jose, S. V. (2025). Investigation Into the Equine Metabolism of Phosphodiesterase‐4 Inhibitor Roflumilast for Potential Doping Control. Drug Testing and Analysis. https://doi.org/10.1002/dta.3822
Vancouver
Philip M, Karakka Kal AK, Subhahar MB, Karatt TK, Graiban FM, Ajeebsanu MM, et al. Investigation Into the Equine Metabolism of Phosphodiesterase‐4 Inhibitor Roflumilast for Potential Doping Control. Drug Testing and Analysis. 2025. doi:10.1002/dta.3822
BibTeX
@article{Philip2025,
author = {Philip, Moses and Karakka Kal, Abdul Khader and Subhahar, Michael Benedict and Karatt, Tajudheen K and Graiban, Fatma Mohammed and Ajeebsanu, Meleparappil Muhammed and Joseph, Marina and Jose, Shantymol V},
title = {Investigation Into the Equine Metabolism of Phosphodiesterase‐4 Inhibitor Roflumilast for Potential Doping Control},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3822}
}
EUVIMED